Shot in the arm for Africa vaccine output as Aspen gets R10bn
30 June 2021 - 18:33
UPDATED 30 June 2021 - 23:25
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, is to receive a €600m (R10.1bn) long-term debt financing package from a consortium of development financiers led by the World Bank’s International Finance Corporation (IFC) to support the development of vaccine manufacturing capacity in Africa.
It is the first financing deal announced by the partnership, which was launched during French President Emanuel Macron’s visit to SA in May...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.